MetaCap

Microbot Medical (MBOT) vs TELA Bio (TELA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

TELA Bio (TELA) has outperformed Microbot Medical (MBOT) over the past year, losing 41.2% versus a loss of 62.8%. Over five years, MBOT leads with a -87.4% price change compared with -94.4% for TELA. Microbot Medical is the larger company by market cap ($45.7 million vs $31.1 million), about 1.5 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MBOT-62.84%TELA-41.15%
+62%-5%-71%
Nov 21, 20251 yearNov 20, 2026
MBOT-88.67%TELA-94.54%
+31%-35%-102%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MBOT versus TELA key metrics
MetricMBOTTELA
Share price$0.68$0.6885
Market cap$45.67M$31.11M
1-day change-8.52%-5.27%
YTD return-66.00%-41.65%
1-year return-62.84%-41.15%
5-year return-87.43%-94.37%
EPS (TTM)$-0.27$-0.74
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$80.28M
Revenue growth (YoY)—+15.84%
Net income (latest FY)$-13.14M$-38.83M
Gross margin—67.69%
Operating margin—-42.05%
Net margin—-48.37%
52-week high$2.86$1.50
52-week low$0.52$0.501
Distance from 52-week high-76.22%-54.10%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+830.88%+202.11%
Average volume922.53K217.44K
Shares outstanding67.16M45.19M
Employees43218
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TELA has outperformed MBOT by 21.7 percentage points over the past year.

About Microbot Medical

MBOT stock →

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.

Health Care · Medical/Dental Instruments · 43 employees

About TELA Bio

TELA stock →

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.

Health Care · Medical/Dental Instruments · 218 employees

MBOT vs TELA FAQ

Which is bigger, Microbot Medical or TELA Bio?

Microbot Medical (MBOT) is larger, with a market capitalization of $45.67M compared with $31.11M for TELA Bio (TELA).

Which stock has performed better over the past year, MBOT or TELA?

TELA returned -41.15% over the past 12 months, compared with -62.84% for MBOT (price return, excluding dividends). Past performance does not predict future results.

Are Microbot Medical and TELA Bio in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons